#IfYouReadOneThingToday - On Pfizer

I'm doing a lot of pandemic-centric reading these days. No surprise, really, as it's entirely normal that this generation-changing event would drive a similar wave of all-encompassing media coverage. (Note to self: this is why we need strong media pillars.)

I'm fascinated by the stories behind some of the major players in the fight against the virus. And few players are more major than Pfizer, the global pharma giant that turned the tide against the pandemic with the first approved vaccine against it.

But as is often the case, the route from here to there, or from there to here, or from despair to salvation, or wherever, is hardly linear. And Pfizer is no exception - which makes for great journalism.

Enjoy...

Inside Pfizer’s Fast, Fraught, and Lucrative Vaccine Distribution:

The company is a hero of the pandemic for its Covid-fighting wonder shot. That doesn’t mean it hasn’t made entire countries angry

By Stephanie Baker, Cynthia Koons, and Vernon Silver

Bloomberg Businessweek

March 4, 2021